FDA approves Sovaldi for chronic hepatitis C
Tuesday, December 10, 2013 - 10:00
in Health & Medicine
The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is the first drug that has demonstrated safety and efficacy to...